Envestnet Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $62.3M | Sell |
1,458,786
-228,033
| -14% | -$12.4M | 0.01% | 772 |
|
|
2026
Q1 | $106M | Sell |
1,686,819
-920,221
| -35% | -$73.6M | 0.03% | 515 |
|
|
2025
Q4 | $249M | Sell |
2,607,040
-262,515
| -9% | -$25.7M | 0.07% | 246 |
|
|
2025
Q3 | $280M | Buy |
2,869,555
+64,643
| +2% | +$6.69M | 0.08% | 234 |
|
|
2025
Q2 | $301M | Buy |
2,804,912
+13,947
| +0.5% | +$1.41M | 0.09% | 209 |
|
|
2025
Q1 | $282M | Buy |
2,790,965
+349,246
| +14% | +$35.2M | 0.09% | 207 |
|
|
2024
Q4 | $218M | Buy |
2,441,719
+43,992
| +2% | +$3.87M | 0.07% | 253 |
|
|
2024
Q3 | $201M | Buy |
2,397,727
+57,030
| +2% | +$4.5M | 0.06% | 277 |
|
|
2024
Q2 | $180M | Sell |
2,340,697
-60,587
| -3% | -$4.43M | 0.06% | 282 |
|
|
2024
Q1 | $164M | Sell |
2,401,284
-14,106
| -0.6% | -$907K | 0.06% | 296 |
|
|
2023
Q4 | $140M | Sell |
2,415,390
-99,333
| -4% | -$5.3M | 0.06% | 315 |
|
|
2023
Q3 | $133M | Buy |
2,514,723
+908,781
| +57% | +$47.7M | 0.06% | 302 |
|
|
2023
Q2 | $86.9M | Buy |
1,605,942
+751,073
| +88% | +$39.2M | 0.04% | 378 |
|
|
2023
Q1 | $42.8M | Buy |
854,869
+71,824
| +9% | +$3.38M | 0.02% | 546 |
|
|
2022
Q4 | $36.2M | Buy |
783,045
+36,312
| +5% | +$1.57M | 0.02% | 574 |
|
|
2022
Q3 | $28.9M | Buy |
746,733
+50,926
| +7% | +$2.04M | 0.02% | 613 |
|
|
2022
Q2 | $25.9M | Buy |
695,807
+110,892
| +19% | +$4.51M | 0.01% | 668 |
|
|
2022
Q1 | $25.9M | Buy |
584,915
+42,991
| +8% | +$1.86M | 0.01% | 732 |
|
|
2021
Q4 | $23M | Buy |
541,924
+83,094
| +18% | +$3.49M | 0.01% | 784 |
|
|
2021
Q3 | $19.9M | Sell |
458,830
-265,999
| -37% | -$11.8M | 0.01% | 797 |
|
|
2021
Q2 | $31M | Sell |
724,829
-36,602
| -5% | -$1.54M | 0.02% | 625 |
|
|
2021
Q1 | $29.4M | Buy |
761,431
+371,049
| +95% | +$14M | 0.02% | 579 |
|
|
2020
Q4 | $14M | Sell |
390,382
-330,439
| -46% | -$11.9M | 0.01% | 762 |
|
|
2020
Q3 | $27.5M | Buy |
720,821
+13,170
| +2% | +$507K | 0.02% | 454 |
|
|
2020
Q2 | $24.8M | Buy |
707,651
+73,193
| +12% | +$2.64M | 0.02% | 461 |
|
|
2020
Q1 | $20.7M | Buy |
634,458
+205,301
| +48% | +$8.02M | 0.02% | 444 |
|
|
2019
Q4 | $19.4M | Buy |
429,157
+15,323
| +4% | +$641K | 0.02% | 545 |
|
|
2019
Q3 | $16.8M | Buy |
413,834
+22,071
| +6% | +$935K | 0.02% | 546 |
|
|
2019
Q2 | $16.8M | Buy |
391,763
+29,024
| +8% | +$1.12M | 0.02% | 533 |
|
|
2019
Q1 | $13.9M | Buy |
362,739
+15,273
| +4% | +$583K | 0.02% | 567 |
|
|
2018
Q4 | $12.3M | Buy |
347,466
+341,226
| +5,468% | +$12.4M | 0.02% | 525 |
|
|
2018
Q3 | $240K | Sell |
6,240
-66,778
| -91% | -$2.33M | ﹤0.01% | 1100 |
|
|
2018
Q2 | $2.39M | Sell |
73,018
-4,248
| -5% | -$128K | 0.01% | 759 |
|
|
2018
Q1 | $2.13M | Sell |
77,266
-406
| -0.5% | -$11K | 0.01% | 689 |
|
|
2017
Q4 | $1.93M | Sell |
77,672
-5,918
| -7% | -$163K | ﹤0.01% | 968 |
|
|
2017
Q3 | $2.44M | Sell |
83,590
-33,227
| -28% | -$918K | 0.01% | 815 |
|
|
2017
Q2 | $3.24M | Buy |
116,817
+6,869
| +6% | +$182K | 0.01% | 739 |
|
|
2017
Q1 | $2.74M | Buy |
109,948
+2,294
| +2% | +$55.8K | 0.01% | 804 |
|
|
2016
Q4 | $2.33M | Sell |
107,654
-10,250
| -9% | -$224K | 0.01% | 853 |
|
|
2016
Q3 | $2.81M | Buy |
117,904
+8,723
| +8% | +$208K | 0.01% | 799 |
|
|
2016
Q2 | $2.55M | Sell |
109,181
-2,200
| -2% | -$47.6K | 0.01% | 904 |
|
|
2016
Q1 | $2.1M | Buy |
111,381
+17,861
| +19% | +$314K | 0.01% | 962 |
|
|
2015
Q4 | $1.73M | Buy |
93,520
+5,243
| +6% | +$93.9K | 0.01% | 1026 |
|
|
2015
Q3 | $1.45M | Sell |
88,277
-3,434
| -4% | -$58.7K | 0.01% | 1093 |
|
|
2015
Q2 | $1.62M | Sell |
91,711
-2,322
| -2% | -$41.5K | 0.01% | 1165 |
|
|
2015
Q1 | $1.67M | Buy |
94,033
+94,020
| +723,231% | +$1.49M | 0.01% | 1059 |
|
|
2014
Q4 | $0 | Sell |
13
-8,579
| -100% | -$110K | ﹤0.01% | 2514 |
|
|
2014
Q3 | $101K | Buy |
8,592
+349
| +4% | +$4.39K | ﹤0.01% | 1289 |
|
|
2014
Q2 | $105K | Sell |
8,243
-1,605
| -16% | -$20.9K | ﹤0.01% | 1193 |
|
|
2014
Q1 | $133K | Buy |
9,848
+5,133
| +109% | +$67.4K | ﹤0.01% | 1052 |
|
|
2013
Q4 | $57K | Buy |
+4,715
| New | +$55.7K | ﹤0.01% | 1178 |
|
Other funds holding BSX
Envestnet Asset Management's BSX Position: Q2 2026 in Review
Envestnet Asset Management reduced its Boston Scientific (BSX) stake by 14% in Q2 2026, selling an estimated $12.4M and leaving 1,458,786 shares worth $62.3M. The position accounts for 0.01% of the portfolio, ranked #772.
Envestnet Asset Management first reported a position in BSX in Q4 2013 and has held it in 51 quarters since. The position peaked at $301M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Envestnet Asset Management held 1,458,786 shares of Boston Scientific worth $62.3M as of Q2 2026.
- Envestnet Asset Management sold 228,033 Boston Scientific shares in Q2 2026, an estimated $12.4M.
- Boston Scientific made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #772 holding.
- Envestnet Asset Management first reported a position in Boston Scientific in Q4 2013 and has held it in 51 quarters since.
- Envestnet Asset Management's Boston Scientific position peaked at $301M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.